Free Trial

Iradimed (IRMD) SEC Filings & 10K Form

Iradimed logo
$48.30
-0.97 (-1.97%)
(As of 11/1/2024 ET)

Recent Iradimed SEC Filings

DateFilerForm TypeView
10/31/2024
3:15 PM
Iradimed (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:00 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Iradimed (Subject)
Form SC 13G
10/15/2024
4:45 PM
Iradimed (Issuer)
Scharen-Guivel Hilda Frederique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:30 PM
Iradimed (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:15 PM
ALLEN MONTY K (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
9:40 AM
ALLEN MONTY K (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:16 AM
Iradimed (Filer)
Form ARS
05/08/2024
11:15 PM
Iradimed (Filer)
Form EFFECT
05/02/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
7:30 AM
Iradimed (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2024
11:03 AM
Iradimed (Subject)
Nine Ten Capital Management LLC (Filed by)
Form SC 13G/A
02/08/2024
7:05 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
8:44 AM
Iradimed (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
12/27/2023
5:30 PM
Iradimed (Issuer)
Susi Roger E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:15 PM
Iradimed (Issuer)
Susi Roger E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
7:05 PM
HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:34 PM
HAWKINS JAMES B (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
4:15 PM
HAWKINS JAMES B (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:30 PM
HAWKINS JAMES B (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
5:00 PM
HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
5:00 PM
ALLEN MONTY K (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
5:00 PM
Iradimed (Issuer)
VUOTO ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
5:00 PM
Iradimed (Issuer)
Scharen-Guivel Hilda Frederique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
5:00 PM
GLENN JOHN (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:05 PM
Iradimed (Issuer)
Susi Roger E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:30 PM
HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:00 PM
HAWKINS JAMES B (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
7:32 PM
HAWKINS JAMES B (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:05 PM
Iradimed (Issuer)
Susi Roger E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
4:01 PM
Iradimed (Issuer)
VUOTO ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:35 PM
Iradimed (Subject)
VUOTO ANTHONY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
3:05 PM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
7:00 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IRMD) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners